Web-Safe Short CV

Psychology education, hospital experience, psycho-oncology research, and independent digital work. The three-page download includes the complete list of twelve published journal outputs.

Download Web-Safe Short CV

Download a three-page public CV: two pages of background and experience, followed by the complete list of twelve published journal outputs. For a tailored application CV, please use Contact or an existing academic thread.

Summary

Chaojie Bu connects psychology, hospital-based psychological treatment and assessment in China, clinical research, and independent digital work. His current research direction is psycho-oncology and cancer survivorship, supported by English-medium psychology education in the US and UK and collaborative neuro-oncology publications.

Education

MSc Psychology with Merit

Bangor University

2019-2020

English-medium postgraduate psychology study. Dissertation: Gender and Age Differences in the Recall of Autobiographical Memories Using the Autobiographical Memory Recollection Test. Degree awarded in December 2020.

BSc Psychology

Arizona State University

2013-2018

English-medium undergraduate psychology study in the United States. Degree awarded in May 2018.

Clinical / Hospital-based Experience

More than five years of frontline health-service experience in a tertiary hospital in China.

Continuing work in psychological treatment and psychological assessment within hospital service workflows.

Clinical research collaboration spanning psychological distress, intervention outcomes, and neuro-oncology.

Previous TMS workflow support is part of past experience, rather than a current operating responsibility; training records are listed separately.

Research Interests

Psycho-oncology and cancer survivorship

Cancer-related psychological distress

Fear of recurrence and progression

Sleep disturbance and quality of life

Psychosocial intervention

Patient-reported outcomes

Biobehavioral mechanisms

Responsible digital health methods

Qualifications

Qualification and appointment.

These are Chinese health-system qualifications and records; they do not establish overseas registration, physician status, or prescribing authority.

2024

Intermediate Health Professional Qualification in Psychological Therapy

China's national health professional technical qualification system; approved in April 2024.

2025

Employer-issued professional appointment record

The July 2025 certificate records Psychological Therapy and an intermediate professional grade. It does not establish a current appointment term or overseas title equivalence.

Professional Development

Selected training.

Training and assessment records, separate from current duties or independent clinical authority.

2024 - Near-infrared brain function imaging

Training assessment passed; a record of training, not independent clinical authority.

2025 - TMS: fundamentals and clinical application

Course completed and assessment passed, April 2025. This does not imply a current TMS operating role.

2021 - National continuing medical education

Central Plains Neurosurgical Critical Care Forum: assessment passed, 10 Category I credits, 30 hours.

Publications

Publication List

Twelve published journal outputs: eleven English-language PubMed records and one Chinese-language article. Two records are Letters; author order and equal contribution are stated individually.

2023

Fear stress promotes glioma progression through inhibition of ferroptosis by enhancing FSP1 stability.

Clinical and Translational Oncology, 25(5), 1378-1388. DOI: 10.1007/s12094-022-03032-1. PubMed PMID: 36484954.

First-listed author; equal contribution with Sen Hu. Journal article.

Fear stress, ferroptosis and glioma progression: a foundation for investigating psychological stress in oncology.

Public source

2025

Effects of cyclic breathing and mindfulness meditation on emotional and physiological states in patients with anxiety disorders.

Journal of Medical Forum, 46(10), 1039-1042, 1049. DOI: 10.20159/j.cnki.jmf.2025.10.007.

First-listed author. Journal article.

Clinical psychological intervention and psychophysiological outcomes. Chinese-language journal article; not a PubMed record.

Public source

2026

Emotional distress impairs immune checkpoint blockade efficacy in recurrent high-grade glioma: insights from tumor in situ fluid analysis.

Neuro-Oncology Advances. DOI: 10.1093/noajnl/vdag040. PubMed PMID: 41778154.

Fourth-listed author. Journal article.

Emotional distress, immunotherapy response and outcomes in recurrent high-grade glioma.

Public source

2026

Dynamic signature for the effectiveness of anti-PD-1 therapy combined with vascular normalization therapy in recurrent glioblastoma: a randomized phase 2 trial.

Cancer, 132(2), e70253. DOI: 10.1002/cncr.70253. PubMed PMID: 41533333.

Fourth-listed author. Journal article.

Randomized phase 2 trial of anti-PD-1 therapy with vascular normalization in recurrent glioblastoma.

Public source

2025

Dynamic tumor in situ fluid circulating tumor DNA postsurgery effectively predicts recurrence and clinical benefits for glioblastomas.

Neurosurgery, 97(3), 671-680. DOI: 10.1227/neu.0000000000003384. PubMed PMID: 40042315.

Fourth-listed author. Journal article.

Longitudinal circulating tumour DNA monitoring after surgery and recurrence prediction.

Public source

2024

Dynamics of tumor in situ fluid circulating tumor DNA in recurrent glioblastomas forecasts treatment efficacy of immune checkpoint blockade coupled with low-dose bevacizumab.

Journal of Cancer Research and Clinical Oncology, 150(10), 466. DOI: 10.1007/s00432-024-05997-8. PubMed PMID: 39422764.

Third-listed author. Journal article.

Treatment-response monitoring using tumour in situ fluid circulating tumour DNA.

Public source

2023

Tracking tumor evolution during the first-line treatment in brain glioma via serial profiling of cell-free tumor DNA from tumor in situ fluid.

Frontiers in Oncology, 13, 1238607. DOI: 10.3389/fonc.2023.1238607. PubMed PMID: 37920153.

Second-listed author; equal contribution. Journal article.

Longitudinal tumour evolution during first-line glioma treatment.

Public source

2023

Molecular and clonal evolution in vivo reveal a common pathway of distant relapse gliomas.

iScience, 26(9), 107528. DOI: 10.1016/j.isci.2023.107528. PubMed PMID: 37649695.

Second-listed author; one of four equal contributors. Journal article.

Molecular and clonal evolution in distant glioma relapse.

Public source

2023

Genomic alterations of oligodendrogliomas at distant recurrence.

Cancer Medicine, 12(16), 17171-17183. DOI: 10.1002/cam4.6327. PubMed PMID: 37533228.

Second-listed author; one of four equal contributors. Journal article.

Genomic changes in oligodendroglioma at distant recurrence.

Public source

2022

Real-time longitudinal analysis of human gliomas reveals in vivo genome evolution and therapeutic impact under standardized treatment.

Clinical and Translational Medicine, 12(7), e956. DOI: 10.1002/ctm2.956. PubMed PMID: 35802830.

Twelfth-listed author. Letter.

Letter reporting longitudinal genome evolution and therapeutic impact.

Public source

2021

Integrating real-time in vivo tumour genomes for longitudinal analysis and management of glioma recurrence.

Clinical and Translational Medicine, 11(11), e567. DOI: 10.1002/ctm2.567. PubMed PMID: 34841677.

Tenth-listed author. Letter.

Letter on longitudinal tumour-genome analysis and glioma recurrence.

Public source

2021

Tumor DNA from tumor in situ fluid reveals mutation landscape of minimal residual disease after glioma surgery and risk of early recurrence.

Frontiers in Oncology, 11, 742037. DOI: 10.3389/fonc.2021.742037. PubMed PMID: 34712610.

Sixth-listed author. Journal article.

Minimal residual disease and early recurrence risk after glioma surgery.

Public source

Patents

Named inventor records.

Inventor roles and grant or publication events are historical records. Current legal validity is not asserted.

Device for sampling, monitoring and treatment using fluid from a brain-tumour surgical cavity

Second named inventor. Chinese invention grant record, May 2022.

CN112603386B

Circulating interventional device for fluid in a brain-tumour interstitial cavity

First named inventor. Published Chinese invention application, April 2026; not presented as a grant.

CN121845640A

Bipolar coagulation forceps integrating irrigation, suction and dissection

Fifth named inventor. Historical Chinese utility-model grant record, January 2022.

CN215384591U

Collaboration

Publication-linked research records.

Publication-linked registered studies

Collaboration documented through named publications and contributions; no principal-investigator, registrant, sponsor, or study-contact role is claimed.

Publication-linked data repositories

Research records linked to co-authored publications. These do not establish personal ownership, an uploader role, or current access to patient-level data.

Projects

Independent digital projects

Mind Portrait

Digital mental health prototype. In development.

SeYun Outfit

Lifestyle app. Preparing for overseas App Store launch.

Survivor Starter Manual

Digital guide. PDF guide prepared; checkout not public.

Skills

Practical capabilities.

Psychological treatment and assessment

Hospital-based psychological work, with careful communication of assessment and support processes.

Clinical and translational collaboration

Research participation across psychological distress, intervention outcomes, neuro-oncology, and longitudinal outcome observation.

Scientific writing and evidence synthesis

Manuscript work, source-based communication, and contributions to published interdisciplinary research.

AI-assisted product delivery

Problem definition, workflow design, prototyping, privacy and support materials, and iterative testing with AI coding tools.

Languages

English

English-medium degree study in the US and UK; academic writing and research communication.

Chinese

Native language; professional and public-facing communication.